Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Neuropharmacology|January 1, 1986
Noradrenergic and cholinergic agents in Korsakoff's syndromeV M O'Donnell, W M Pitts, W E Fann
Archives of Sexual Behavior|November 2, 2013
Monoamines and ovarian hormone-linked sexual and emotional changes: A reviewD S Janowsky, W E Fann, J M Davis
The Journal of Clinical Psychiatry|June 1, 1983
Alprazolam in older depressed inpatientsW M Pitts, W E Fann, C Sajadi, et al.
Clinical Pharmacology and Therapeutics|October 1, 1983
Multiple-dose doxepin kinetics in depressed patientsR D Faulkner, W M Pitts, C S Lee, et al.
The American Journal of Psychiatry|July 1, 1977
Clinical research techniques in tardive dyskinesiaW E Fann, J R Stafford, R L Malone, et al.
The Journal of Clinical Psychiatry|May 1, 1983
Bupropion in depression: a tri-center placebo-controlled studyW M Pitts, W E Fann, A E Halaris, et al.
Schizophrenia Research|January 1, 1993
Association between genetic variation at the porphobilinogen deaminase gene and schizophreniaA R Sanders, D E Rincon-Limas, R Chakraborty, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 1, 1986
Abstinence improves cerebral perfusion and brain volume in alcoholic neurotoxicity without Wernicke-Korsakoff syndromeY Ishikawa, J S Meyer, N Tanahashi, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 1985
Cerebral atrophy and hypoperfusion improve during treatment of Wernicke-Korsakoff syndromeJ S Meyer, N Tanahashi, Y Ishikawa, et al.
Pageof 3